Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Amanda Blackmon

Clinical Assistant Professor

City Of Hope National Medical Center

United States

Research Interests

Explore related searches

Professors in United States

About

Amanda Blackmon is a Clinical Assistant Professor at City Of Hope National Medical Center in the United States. Her research primarily focuses on hematopoietic cell transplantation, acute myeloid leukemia, and chronic lymphocytic leukemia. Recent articles include investigations into conditioning regimens for transplantation and the efficacy of various therapies in hematologic malignancies.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2021

Year:

2020

Collaborators (2)

HyunJun Kang

Staff Scientist

City Of Hope National Medical Center

UNITED STATES

View details

Jose Tinajero

City of Hope

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amanda Blackmon

Research Interests

Explore related searches

About

Articles (13)

The efficacy of targeted and immune‐based therapies in adults with TP53‐mutated acute lymphoblastic leukaemia

TP53 Mutations are Associated with CD19 Negative Relapse and Inferior Outcomes after Blinatumomab in Adults with ALL

Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect

Editorial: Molecular MRD testing in patients with acute myeloid leukemia

Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid leukemia with measurable residual disease

Pharmacological Inhibition of miR-126 Enhances Venetoclax Activity in Acute Myeloid Leukemia.

FLAG-Ida-Venetoclax vs CLIA-venetoclax for relapsed and refractory AML during a fludarabine shortage: A single center experience.

Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.

Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal Impairment.

Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis.

Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation

An update on acalabrutinib to treat chronic lymphocytic leukemia.

Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient Selection.

Collaborators (2)

HyunJun Kang

Jose Tinajero

Make your next move.